Quantitative flow ratio as a new tool for angiography-based physiological evaluation of coronary artery disease: a review.

angiography-derived fractional flow reserve coronary physiology and outcome coronary physiology and resorbable scaffold coronary physiology in acute coronary syndrome coronary physiology in aortic stenosis percutaneous coronary intervention quantitative flow ratio

Journal

Future cardiology
ISSN: 1744-8298
Titre abrégé: Future Cardiol
Pays: England
ID NLM: 101239345

Informations de publication

Date de publication:
11 2021
Historique:
pubmed: 20 3 2021
medline: 29 1 2022
entrez: 19 3 2021
Statut: ppublish

Résumé

The functional evaluation of coronary stenoses has obtained important clinical results in recent years, resulting in strong guideline recommendations. Nonetheless, the use of coronary wire-based functional evaluation has not yet become part of the routine in catheterization laboratories for several reasons, including the need to advance a wire into the coronary vessel to interrogate the stenosis. Angiography-derived indexes have been introduced to expand the current use of physiology to estimate the functional meaning of a stenosis on the basis of angiographic data only. The most studied and validated angiography-derived index is certainly the quantitative flow ratio. This article will summarize the basics of the quantitative flow ratio, the related validation studies and its current and future applications. Lay abstract Coronary arteries are the main vessels that carry blood and oxygen to the heart muscle, ensuring its functionality. In cardiology, coronary stenoses are defined as pathological narrowing of one or more of these vessels, which can lead to a critical reduction in blood flow, ischemic problems and myocardial infarction. Currently, percutaneous coronary intervention is considered the first-line treatment of myocardial infarction. This technique consists of a procedure in which the stenosis is resolved and proper blood flow is restored thanks to balloon inflation and stent implantation through a percutaneous procedure performed under local anesthesia. Coronary angiography was, for many years, the only available tool to diagnose and assess the consequences of coronary atherosclerosis, becoming the standard reference in the study of ischemic heart disease, allowing us to routinely describe the severity of coronary stenosis or the severity of the disease based on the number of vessels affected. Subsequently, the introduction of invasive methods to assess coronary physiology allowed us to obtain a precise assessment regarding the physiological impact of stenoses located in main vessels while demonstrating the poor diagnostic performance of angiography to assess the functional impact of these stenoses. Among these coronary physiology techniques, quantitative flow ratio has recently been the object of many investigations. In contrast to invasive techniques that can be performed only by advancing a wire into the coronary artery, quantitative flow ratio allows us to perform a functional evaluation of coronary stenoses on the basis of angiographic data only. Given its potential, this work will summarize the basics of quantitative flow ratio, the main validation studies and its current and future applications in interventional cardiology.

Autres résumés

Type: plain-language-summary (eng)
Lay abstract Coronary arteries are the main vessels that carry blood and oxygen to the heart muscle, ensuring its functionality. In cardiology, coronary stenoses are defined as pathological narrowing of one or more of these vessels, which can lead to a critical reduction in blood flow, ischemic problems and myocardial infarction. Currently, percutaneous coronary intervention is considered the first-line treatment of myocardial infarction. This technique consists of a procedure in which the stenosis is resolved and proper blood flow is restored thanks to balloon inflation and stent implantation through a percutaneous procedure performed under local anesthesia. Coronary angiography was, for many years, the only available tool to diagnose and assess the consequences of coronary atherosclerosis, becoming the standard reference in the study of ischemic heart disease, allowing us to routinely describe the severity of coronary stenosis or the severity of the disease based on the number of vessels affected. Subsequently, the introduction of invasive methods to assess coronary physiology allowed us to obtain a precise assessment regarding the physiological impact of stenoses located in main vessels while demonstrating the poor diagnostic performance of angiography to assess the functional impact of these stenoses. Among these coronary physiology techniques, quantitative flow ratio has recently been the object of many investigations. In contrast to invasive techniques that can be performed only by advancing a wire into the coronary artery, quantitative flow ratio allows us to perform a functional evaluation of coronary stenoses on the basis of angiographic data only. Given its potential, this work will summarize the basics of quantitative flow ratio, the main validation studies and its current and future applications in interventional cardiology.

Identifiants

pubmed: 33739146
doi: 10.2217/fca-2020-0199
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1435-1452

Auteurs

Enrico Cerrato (E)

Interventional Cardiology Unit, San Luigi Gonzaga University Hospital, Orbassano & Rivoli Infermi Hospital, Rivoli, Turin, Italy.

Hernan Mejía-Rentería (H)

Department of Cardiology, Hospital Clinico San Carlos, Instituto de Investigación Sanitaria San Carlos & Universidad Complutense de Madrid, Madrid, Spain.

Alfonso Franzè (A)

Interventional Cardiology Unit, San Luigi Gonzaga University Hospital, Orbassano & Rivoli Infermi Hospital, Rivoli, Turin, Italy.

Giorgio Quadri (G)

Interventional Cardiology Unit, San Luigi Gonzaga University Hospital, Orbassano & Rivoli Infermi Hospital, Rivoli, Turin, Italy.

Davide Belliggiano (D)

Interventional Cardiology Unit, San Luigi Gonzaga University Hospital, Orbassano & Rivoli Infermi Hospital, Rivoli, Turin, Italy.

Simone Biscaglia (S)

Cardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, Cona, Italy.
Maria Cecilia Hospital, GVM Care & Research, Cotignola, RA, Italy.

Luca Lo Savio (L)

Interventional Cardiology Unit, Rivoli Infermi Hospital, Rivoli, Turin, Italy.

Fabio Spataro (F)

Interventional Cardiology Unit, Rivoli Infermi Hospital, Rivoli, Turin, Italy.

Andrea Erriquez (A)

Cardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, Cona, Italy.
Maria Cecilia Hospital, GVM Care & Research, Cotignola, RA, Italy.

Federico Giacobbe (F)

Interventional Cardiology Unit, San Luigi Gonzaga University Hospital, Orbassano & Rivoli Infermi Hospital, Rivoli, Turin, Italy.

Carlos Vergara-Uzcategui (C)

Department of Cardiology, Hospital Clinico San Carlos, Instituto de Investigación Sanitaria San Carlos & Universidad Complutense de Madrid, Madrid, Spain.

Domenico di Girolamo (D)

Interventional Cardiology, Casa di Cura San Michele, Maddaloni, Caserta, Italy.

Matteo Tebaldi (M)

Cardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, Cona, Italy.
Maria Cecilia Hospital, GVM Care & Research, Cotignola, RA, Italy.

Ferdinando Varbella (F)

Interventional Cardiology Unit, San Luigi Gonzaga University Hospital, Orbassano & Rivoli Infermi Hospital, Rivoli, Turin, Italy.

Gianluca Campo (G)

Cardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, Cona, Italy.
Maria Cecilia Hospital, GVM Care & Research, Cotignola, RA, Italy.

Javier Escaned (J)

Department of Cardiology, Hospital Clinico San Carlos, Instituto de Investigación Sanitaria San Carlos & Universidad Complutense de Madrid, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH